There is a lot of discussion about the pharmacological treatment of ADHD. This discussion, however, might miss an important aspect, namely whether our general understanding of how pharmacological treatments work in developmental diseases is correct. I say, we miss our opportunities!
Common sense psychology predicts that people with Attention Deficit Hyperactivity Disorder (ADHD) run more risks, because they are more impulsive than people without ADHD. We systematically reviewed the scientific literature and discovered that this presumption may not be true.
Adults with ADHD are at high risk to be confronted with negative attitudes and beliefs which can be described as stigmatization. In our research group at the Department of Clinical and Developmental Neuropsychology, we developed a disease specific assessment tool, measuring various facets of stigmatization towards adults with ADHD.
The Dutch Neuropsychological Society celebrated its 50th anniversary on the first of November 2013. Renowned international researchers presented their work and gave state-of-the-art overviews of the latest findings. Several topics were discussed including the “what” and “where” pathways in vision, environmentally induced amnesia and the mystery of the frontal lobe.
Distraction is a major cause of traffic accidents, keeping your eyes on the road in front of you is apparently difficult. Whether in a car or on the bike, people are easily distracted, certainly in these times with all sorts of smart media at hand.
Adults with ADHD have long been known to have problems with so-called executive functions, such as planning, organizing and structuring. Recent studies also suggested memory impairments. In thorough analysis, we showed that adults with ADHD do not have an increased forgetfulness, however that memory is adversely affected by executive dysfunctions.